Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Candel Therapeutics, Inc. (CADL) had Operating Cash Flow per Share of $-0.29 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-8.86M |
|
-- |
|
-- |
|
$16.28M |
|
$-16.28M |
|
$7.42M |
|
$-8.86M |
|
$-8.86M |
|
$-8.86M |
|
$-8.86M |
|
$-8.86M |
|
$-8.86M |
|
$-16.28M |
|
$-16.14M |
|
62.36M |
|
62.36M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$197.75M |
|
$2.08M |
|
$4.17M |
|
$201.92M |
|
$7.05M |
|
$47.48M |
|
$56.84M |
|
$63.89M |
|
$138.03M |
|
$138.03M |
|
$138.03M |
|
73.26M |
|
| Cash Flow Statement Financials | |
$-18.04M |
|
$-0.68M |
|
$93.81M |
|
$120.15M |
|
$195.25M |
|
$75.10M |
|
$1.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.05 |
|
-- |
|
-- |
|
0.26 |
|
0.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.42% |
|
-6.42% |
|
-4.39% |
|
-4.78% |
|
$1.88 |
|
$-0.30 |
|
|
Operating Cash Flow per Share |
$-0.29 |